Immune evasion by staphylococci (Q33991798)

30 July 2017

1 reference

title

Immune evasion by staphylococci (English)

1 reference

evasion of host immune response

30 July 2017

1 reference

Timothy J Foster

1

1 reference

PubMed ID

16322743

30 July 2017

language of work or name

English

0 references

publication date

1 December 2005

1 reference

Nature Reviews Microbiology

30 July 2017

1 reference

30 July 2017

3

1 reference

30 July 2017

948-958

1 reference

30 July 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nrmicro1289

30 July 2017

0 references

cites work

What determines nasal carriage of Staphylococcus aureus?

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Staphylococcus aureus infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Surface protein adhesins of Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Iron-regulated surface determinants (Isd) of Staphylococcus aureus: stealing iron from heme

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Staphylococcus aureus capsular polysaccharides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Exotoxins of Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Sortase-catalysed anchoring of surface proteins to the cell wall of Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Characterization of novel LPXTG-containing proteins of Staphylococcus aureus identified from genome sequences

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

The molecular basis of fibronectin-mediated bacterial adherence to host cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Pathogenic bacteria attach to human fibronectin through a tandem beta-zipper

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Bacterial fibronectin-binding proteins and endothelial cell surface fibronectin mediate adherence of Staphylococcus aureus to resting human endothelial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

N-terminal residues of the chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking formylated peptide receptor but not C5a receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Staphylococcus aureus extracellular adherence protein serves as anti-inflammatory factor by inhibiting the recruitment of host leukocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Beta-barrel membrane protein folding and structure viewed through the lens of alpha-hemolysin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Community-acquired methicillin-resistant Staphylococcus aureus: an emerging pathogen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Differential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Mutational analysis of the interaction between staphylococcal protein A and human IgG1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Protein A is a virulence factor in Staphylococcus aureus arthritis and septic death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Microarray-based analysis of the Staphylococcus aureus sigmaB regulon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Characterization of the interaction between the Staphylococcus aureus clumping factor (ClfA) and fibrinogen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Expression of staphylococcal clumping factor A impedes macrophage phagocytosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

The fibronectin-binding MSCRAMM FnbpA of Staphylococcus aureus is a bifunctional protein that also binds to fibrinogen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Epidemiology of capsular and surface polysaccharide in Staphylococcus aureus infections complicated by bacteraemia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Overproduction of type 8 capsular polysaccharide augments Staphylococcus aureus virulence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Staphylococcus aureus microcapsule expression attenuates bacterial virulence in a rat model of experimental endocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Immune evasion by a staphylococcal complement inhibitor that acts on C3 convertases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Inhibition of complement activation by a secreted Staphylococcus aureus protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Identification and characterization of the C3 binding domain of the Staphylococcus aureus extracellular fibrinogen-binding protein (Efb)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Anti-opsonic properties of staphylokinase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Bacterial evasion of innate host defenses--the Staphylococcus aureus lesson

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

How do bacteria resist human antimicrobial peptides?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Human alpha -defensins neutralize fibrinolytic activity exerted by staphylokinase.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Lysozyme is an inducible marker of macrophage activation in murine tissues as demonstrated by in situ hybridization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Chronic granulomatous disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Survival of Staphylococcus aureus inside neutrophils contributes to infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Role and regulation of the superoxide dismutases of Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

MntR modulates expression of the PerR regulon and superoxide resistance in Staphylococcus aureus through control of manganese uptake.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Multiple methionine sulfoxide reductase genes in Staphylococcus aureus: expression of activity and roles in tolerance of oxidative stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Streptococcus pyogenes and human neutrophils: a paradigm for evasion of innate host defense by bacterial pathogens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Pathogenesis of infections due to coagulase-negative staphylococci

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Insights on Evolution of Virulence and Resistance from the Complete Genome Analysis of an Early Methicillin-Resistant Staphylococcus aureus Strain and a Biofilm-Producing Methicillin-Resistant Staphylococcus epidermidis Strain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Bacterial biofilms: a common cause of persistent infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

The Fbe (SdrG) protein of Staphylococcus epidermidis HB promotes bacterial adherence to fibrinogen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Induction of Staphylococcus epidermidis biofilm formation via proteolytic processing of the accumulation-associated protein by staphylococcal and host proteases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Biofilm formation, icaADBC transcription, and polysaccharide intercellular adhesin synthesis by staphylococci in a device-related infection model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Key role of poly-γ-dl-glutamic acid in immune evasion and virulence of Staphylococcus epidermidis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Molecular pathogenesis of Bacillus anthracis infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

An inflammatory polypeptide complex from Staphylococcus epidermidis: isolation and characterization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Regulated expression of pathogen-associated molecular pattern molecules in Staphylococcus epidermidis: quorum-sensing determines pro-inflammatory capacity and production of phenol-soluble modulins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Staphylococcal toxin induced preferential and prolonged in vivo deletion of innate-like B lymphocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

A model B-cell superantigen and the immunobiology of B lymphocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

The disease spectrum, epidemiology, and etiology of toxic-shock syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Superantigens: microbial agents that corrupt immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

31 March 2020

Bacterial superantigens

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Selective expansion of T cells expressing V beta 2 in toxic shock syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Two adjacent residues in staphylococcal enterotoxins A and E determine T cell receptor V beta specificity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Differential effects of superantigen-induced "anergy" on priming and effector stages of a T cell-dependent antibody response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Interplay between superantigens and immunoreceptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Staphylococcus aureus expresses a major histocompatibility complex class II analog

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Dual effects of extracellular adherence protein from Staphylococcus aureus on peripheral blood mononuclear cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

31 March 2020

Infective endocarditis.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Pathogenesis of streptococcal and staphylococcal endocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Fibronectin-binding proteins of Staphylococcus aureus mediate activation of human platelets via fibrinogen and fibronectin bridges to integrin GPIIb/IIIa and IgG binding to the FcgammaRIIa receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Vaccination with a recombinant fragment of collagen adhesin provides protection against Staphylococcus aureus-mediated septic death

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Development of StaphVAX, a polysaccharide conjugate vaccine against S. aureus infection: from the lab bench to phase III clinical trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Anti-Clumping Factor A Immunoglobulin Reduces the Duration of Methicillin-ResistantStaphylococcus aureusBacteremia in an Experimental Model of Infective Endocarditis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

A humanized monoclonal antibody targeting Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Fatal outcome of bacteraemic patients caused by infection with staphylokinase-deficient Staphylococcus aureus strains

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Use of multiplex PCR to identify Staphylococcus aureus adhesins involved in human hematogenous infections

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Two allelic forms of the aureolysin gene (aur) within Staphylococcus aureus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Evolution of the lectin-complement pathway and its role in innate immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

7 January 2021

Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

7 January 2021

The role of staphylococcal polysaccharide microcapsule expression in septicemia and septic arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

7 January 2021

Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

7 January 2021

A 140-kilodalton extracellular protein is essential for the accumulation of Staphylococcus epidermidis strains on surfaces

1 reference

https://api.crossref.org/works/10.1038%2FNRMICRO1289

7 January 2021

Identifiers

DOI

10.1038/NRMICRO1289

1 reference

PubMed ID

16322743

Dimensions Publication ID

30 July 2017

0 references

1 reference

PubMed ID

16322743